247 related articles for article (PubMed ID: 31487117)
1. Effect on total microbial load and community composition with two vs six-week topical Cadexomer Iodine for treating chronic biofilm infections in diabetic foot ulcers.
Malone M; Schwarzer S; Radzieta M; Jeffries T; Walsh A; Dickson HG; Micali G; Jensen SO
Int Wound J; 2019 Dec; 16(6):1477-1486. PubMed ID: 31487117
[TBL] [Abstract][Full Text] [Related]
2. Effect of cadexomer iodine on the microbial load and diversity of chronic non-healing diabetic foot ulcers complicated by biofilm in vivo.
Malone M; Johani K; Jensen SO; Gosbell IB; Dickson HG; McLennan S; Hu H; Vickery K
J Antimicrob Chemother; 2017 Jul; 72(7):2093-2101. PubMed ID: 28402558
[TBL] [Abstract][Full Text] [Related]
3. A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers.
Schwartz JA; Lantis JC; Gendics C; Fuller AM; Payne W; Ochs D
Int Wound J; 2013 Apr; 10(2):193-9. PubMed ID: 23136838
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a topical concentrated surfactant gel on microbial communities in non-healing diabetic foot ulcers with chronic biofilm infections: A proof-of-concept study.
Malone M; Radzieta M; Schwarzer S; Jensen SO; Lavery LA
Int Wound J; 2021 Aug; 18(4):457-466. PubMed ID: 33476485
[TBL] [Abstract][Full Text] [Related]
5. Cadexomer iodine effectively reduces bacterial biofilm in porcine wounds ex vivo and in vivo.
Roche ED; Woodmansey EJ; Yang Q; Gibson DJ; Zhang H; Schultz GS
Int Wound J; 2019 Jun; 16(3):674-683. PubMed ID: 30868761
[TBL] [Abstract][Full Text] [Related]
6. Cadexomer iodine provides superior efficacy against bacterial wound biofilms in vitro and in vivo.
Fitzgerald DJ; Renick PJ; Forrest EC; Tetens SP; Earnest DN; McMillan J; Kiedaisch BM; Shi L; Roche ED
Wound Repair Regen; 2017 Jan; 25(1):13-24. PubMed ID: 27859922
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cadexomer Iodine in the Treatment of Chronic Ulcers: A Randomized, Multicenter, Controlled Trial.
Raju R; Kethavath SN; Sangavarapu SM; Kanjarla P
Wounds; 2019 Mar; 31(3):85-90. PubMed ID: 30720444
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG
Cochrane Database Syst Rev; 2010 Jan; (1):CD003557. PubMed ID: 20091548
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ovington LG
Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG; Martyn-St James M; Richardson R
Cochrane Database Syst Rev; 2013 Dec; (12):CD003557. PubMed ID: 24363048
[TBL] [Abstract][Full Text] [Related]
11. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
[TBL] [Abstract][Full Text] [Related]
12. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds.
Zhou LH; Nahm WK; Badiavas E; Yufit T; Falanga V
Br J Dermatol; 2002 Mar; 146(3):365-74. PubMed ID: 11952535
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo.
Johani K; Malone M; Jensen SO; Dickson HG; Gosbell IB; Hu H; Yang Q; Schultz G; Vickery K
J Antimicrob Chemother; 2018 Feb; 73(2):494-502. PubMed ID: 29165561
[TBL] [Abstract][Full Text] [Related]
14. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial.
Apelqvist J; Ragnarson Tennvall G
Acta Derm Venereol; 1996 May; 76(3):231-5. PubMed ID: 8800307
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers.
Skog E; Arnesjö B; Troëng T; Gjöres JE; Bergljung L; Gundersen J; Hallböök T; Hessman Y; Hillström L; Månsson T; Eilard U; Eklöff B; Plate G; Norgren L
Br J Dermatol; 1983 Jul; 109(1):77-83. PubMed ID: 6344906
[TBL] [Abstract][Full Text] [Related]
16. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.
Nelson EA; O'Meara S; Craig D; Iglesias C; Golder S; Dalton J; Claxton K; Bell-Syer SE; Jude E; Dowson C; Gadsby R; O'Hare P; Powell J
Health Technol Assess; 2006 Apr; 10(12):iii-iv, ix-x, 1-221. PubMed ID: 16595081
[TBL] [Abstract][Full Text] [Related]
17. Cadexomer iodine in ulcers colonised by Pseudomonas aeruginosa.
Danielsen L; Cherry GW; Harding K; Rollman O
J Wound Care; 1997 Apr; 6(4):169-72. PubMed ID: 9256715
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study on effect of bacterial load in diabetic foot ulcers dealing with iodophor and rivanol respectively].
Chen W; Xu K; Zhang H; Shang Y; Hao P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):567-70. PubMed ID: 18630437
[TBL] [Abstract][Full Text] [Related]
19. A review of iodine-based compounds, with a focus on biofilms: results of an expert panel.
Wolcott RD; Cook RG; Johnson E; Jones CE; Kennedy JP; Simman R; Woo K; Weir D; Schultz G; Hermans MH
J Wound Care; 2020 Jul; 29(Sup7):S38-S43. PubMed ID: 32654617
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy.
Akiyama H; Oono T; Saito M; Iwatsuki K
J Dermatol; 2004 Jul; 31(7):529-34. PubMed ID: 15492416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
